Aim: Interleukin-18 (IL-18) and fetuin-A have been implicated in atherosclerosis. Preliminary evidence suggests that ankylosing spondylitis (AS) is associated with an increased risk of atherosclerosis. The aim of the present study was to investigate possible abnormalities in IL-18 and fetuin-A levels in AS
Background—Interleukin (IL)-18 is a potent proinflammatory cytokine with potential atherogenic prope...
BACKGROUND: Cardiovascular mortality is increased in patients with ankylosing spondylitis. A possibl...
OBJECTIVE: Recent studies have implicated increased oxidative stress in the pathogenesis of Ankylosi...
Aim: Interleukin-18 (IL-18) and fetuin-A have been implicated in atherosclerosis. Preliminary eviden...
To examine serum interleukin 18 (IL-18), fetuin-A, soluble intercellular adhesion molecule-1 (sICAM-...
Objective: To investigate the associations of IL-18 serum levels with serum lipids, cardiovascular r...
Atherosclerosis has been shown to be increased in chronic inflammatory diseases including ankylosing...
OBJECTIVES: New bone formation is one of the hallmark characteristics of ankylosing spondylitis, whi...
Our study aimed to evaluate the association between fetuin-A levels and the presence of radiographic...
Ankylosing spondylitis (AS) is an autoimmune disease affecting parts of the skeletal structure in pa...
Background Ankylosing spondylitis (AS) is a systemic inflammatory disorder with extra-articular fea...
INTRODUCTION: Spondyloarthritis (SpA) comprises a group of diseases often associated with HLA-B27 an...
Fetuin-A, also known as alpha 2-Heremans-Schmid glycoprotein (AHSG), is a member of the cystatin sup...
The pathology of ankylosing spondylitis (AS) suggests that certain cytokines and matrix metalloprote...
International audienceBACKGROUND: Tissue factor, the main initiator of blood coagulation, is release...
Background—Interleukin (IL)-18 is a potent proinflammatory cytokine with potential atherogenic prope...
BACKGROUND: Cardiovascular mortality is increased in patients with ankylosing spondylitis. A possibl...
OBJECTIVE: Recent studies have implicated increased oxidative stress in the pathogenesis of Ankylosi...
Aim: Interleukin-18 (IL-18) and fetuin-A have been implicated in atherosclerosis. Preliminary eviden...
To examine serum interleukin 18 (IL-18), fetuin-A, soluble intercellular adhesion molecule-1 (sICAM-...
Objective: To investigate the associations of IL-18 serum levels with serum lipids, cardiovascular r...
Atherosclerosis has been shown to be increased in chronic inflammatory diseases including ankylosing...
OBJECTIVES: New bone formation is one of the hallmark characteristics of ankylosing spondylitis, whi...
Our study aimed to evaluate the association between fetuin-A levels and the presence of radiographic...
Ankylosing spondylitis (AS) is an autoimmune disease affecting parts of the skeletal structure in pa...
Background Ankylosing spondylitis (AS) is a systemic inflammatory disorder with extra-articular fea...
INTRODUCTION: Spondyloarthritis (SpA) comprises a group of diseases often associated with HLA-B27 an...
Fetuin-A, also known as alpha 2-Heremans-Schmid glycoprotein (AHSG), is a member of the cystatin sup...
The pathology of ankylosing spondylitis (AS) suggests that certain cytokines and matrix metalloprote...
International audienceBACKGROUND: Tissue factor, the main initiator of blood coagulation, is release...
Background—Interleukin (IL)-18 is a potent proinflammatory cytokine with potential atherogenic prope...
BACKGROUND: Cardiovascular mortality is increased in patients with ankylosing spondylitis. A possibl...
OBJECTIVE: Recent studies have implicated increased oxidative stress in the pathogenesis of Ankylosi...